Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
International Ophthalmology|March 22, 2025
Comparison of tear cytokines and neuropeptides, ocular surface parameters, and corneal nerve structure in patients with early-stage diabetes mellitus and control subjectsHilal Toprak Tellioglu, Ozlem Dikmetas, Sibel Kocabeyoglu, et al.Acta Ophthalmologica|November 3, 2009
The association of ocular blood flow with haemorheological parameters in primary open-angle and exfoliative glaucomaMehmet Ali Sekeroglu, Murat Irkec, Mehmet Cem Mocan, et al.Clinical Rheumatology|May 20, 2025
Systemic secukinumab treatment in patients with ankylosing spondylitis: the relationship between systemic and tear proinflammatory cytokines and ocular surface findings-a pilot studyOzlem Dikmetas, Yasemin Kapucu, Semih Coşan, et al.Expert Opinion on Drug Safety|October 20, 2021
A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertensionAndreas Katsanos, Ivano Riva, Banu Bozkurt, et al.Journal of Glaucoma|February 3, 2015
Intraocular Pressure Characteristics of Exfoliative Glaucoma and Exfoliation Syndrome as Determined With the Water Drinking TestMehmet C Mocan, Burcu Kasim, Ersin Muz, et al.The British Journal of Ophthalmology|October 15, 2009
Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucomaAnastasios G P Konstas, Gábor Holló, Dimitrios Mikropoulos, et al.Progress in Retinal and Eye Research|November 25, 2018
Reconsidering the central role of mucins in dry eye and ocular surface diseasesChristophe Baudouin, Maurizio Rolando, Jose M Benitez Del Castillo, et al.Expert Opinion on Drug Safety|January 22, 2021
The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerabilityAnastasios G Konstas, Antoine Labbé, Andreas Katsanos, et al.Expert Opinion on Drug Safety|September 21, 2020
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability reviewAnastasios G Konstas, Leopold Schmetterer, Vital P Costa, et al.Neuromuscular Disorders : NMD|January 4, 2022
The functional and structural evaluation of small fibers in asymptomatic carriers of TTR p.Val50Met (Val30Met) mutationCan Ebru Bekircan-Kurt, Ezgi Yilmaz, Doruk Arslan, et al.Pageof 10